APA

Jung U., Foley J. E., Erdmann A. A., Toda Y., Borenstein T., Mariotti J. & Fowler D. H. (20061212). Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy. : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chicago

Jung Unsu, Foley Jason E, Erdmann Andreas A, Toda Yoko, Borenstein Todd, Mariotti Jacopo and Fowler Daniel H. 20061212. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy. : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Harvard

Jung U., Foley J. E., Erdmann A. A., Toda Y., Borenstein T., Mariotti J. and Fowler D. H. (20061212). Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy. : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MLA

Jung Unsu, Foley Jason E, Erdmann Andreas A, Toda Yoko, Borenstein Todd, Mariotti Jacopo and Fowler Daniel H. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy. : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20061212.